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Background
The role of Mycoplasma pneumoniae and Chlamydia
pneumoniae infection in acute asthma is determined by
the ability of these pathogens to initiate the development
of bronchial obstruction and to increase the frequency
and severity of the disease exacerbations. Studies that
have been previously published showed contradictory
results, thus further research on this subject need to be
performed.
Our study aimed to reveal immunological peculiarities
in patient with asthma triggered by atypical pathogens
in order to improve diagnosis and management of this
category of patients.
Materials and methods
The study included 54 children aged from 1 to 18 years,
hospitalized with asthma exacerbation. In all cases immu-
nological essays were performed in order to assess specific
antibodies (IgA/ IgM/ IgG to Mycoplasma pneumoniae
and Chlamydia pneumoniae; total serum IgE levels
examined using ELISA method.
Results
Serological markers for atypical pathogens were identified
in 32 (59%) children investigated. Acute Mycoplasma
pneumoniae infection was estimated in 13% of cases,
chronic infection with Mycoplasma pneumoniae was diag-
nosed in 26% of children. Chlamydia pneumoniae caused
acute infection in 20.4% of those investigated. Also, total
serum IgE levels in children with asthma and acute infec-
tion was 1.5-fold higher than in the serologically-negative
group (916.0±236.0 IU/ml vs. 647.9±104.6 IU/ml, respec-
tively, p>0.05). Likewise, a significant correlation of the
total serum IgE levels with IgG anti-Mycoplasma pneu-
moniae antibodies was identified (r=0,58; p<0,01). This
indicates that Mycoplasma pneumoniae infection may
be involved in mechanisms of allergic sensitization,
hyper-IgE production and asthma pathogenesis in
children.
Conclusions
Immunological diagnosis of infections with atypical
pathogens associated with asthma exacerbations may be
helpful in improving the complex management of
children with asthma. It offers the possibility to use the
ethiotropic antibacterial therapy that may have a positive
impact on the disease severity and the level of asthma
control.
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